Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the American College of Cardiology’s Annual Scientific ...

Vascular dementia occurs when blood vessels that deliver blood to the brain become damaged. Our blood contains oxygen and nutrients that help the brain cells to work properly. When blood vessels are ...

A novel therapeutic showed significant promise in slowing aortic valve calcification, potentially extending time until or eliminating need for transcatheter or surgical intervention for stenosis, ...

So, there is a reasonable theory as to why K2 might reduce the risk of calcification of the blood vessels, which is highly (but not perfectly) associated with blockages in the arteries to the heart.

MR imaging of iliofemoral peripheral vascular calcifications using proton density-weighted, in-phase three-dimensional stack-of-stars gradient echo. Two-dimensional single-shot diffusion-weighted ...